Medicinal Products

Seroquel XR 150 mg tablete s produljenim oslobađanjem

Name Seroquel XR 150 mg tablete s produljenim oslobađanjem
Marketing Authorisation Number HR-H-202528018
Active Substance quetiapinum
Pharmaceutical Form tableta s produljenim oslobađanjem
Strength 150 mg
Packaging [MA Number for Packaging] 10 tableta u blisteru, u kutiji  [HR-H-202528018-01]
30 tableta u blisteru, u kutiji  [HR-H-202528018-02]
50 tableta u blisteru, u kutiji  [HR-H-202528018-03]
60 tableta u blisteru, u kutiji  [HR-H-202528018-04]
100 tableta u blisteru, u kutiji  [HR-H-202528018-05]
Manufacturer AstraZeneca UK Limited, Macclesfield, Cheshire, Ujedinjeno Kraljevstvo;
AndersonBrecon (UK) Limited, Hereford, Ujedinjeno Kraljevstvo;
AstraZeneca GmbH, Wedel, Njemačka
Marketing Authorisation Holder AstraZeneca d.o.o., Radnička cesta 80, Zagreb
Marketing Authorisation Date 20.04.2016
MA Period of Validity unlimited
Classification Number UP/I-530-09/15-02/69
Registration Number 381-12-01/70-16-07
Composition jedna tableta s produljenim oslobađanjem sadrži 150 mg kvetiapina (u obliku kvetiapinfumarata)
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code N05AH04
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Podsjetnik o važnosti nadziranja metaboličkih parametara tijekom liječenja kvetiapinom, verzija 2
Back